Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Sex differences in obstructive sleep apnea: Is it a menopause issue?

Schiza SE, Bouloukaki I.

Sleep Med Rev. 2019 Nov 20;49:101246. doi: 10.1016/j.smrv.2019.101246. [Epub ahead of print] No abstract available.

PMID:
31812851
2.

Carbonic anhydrase, obstructive sleep apnea and hypertension: Effects of intervention.

Hoff E, Zou D, Schiza S, Demir Y, Grote L, Bouloukaki I, Beydemir Ş, Eskandari D, Stenlöf K, Hedner J.

J Sleep Res. 2019 Dec 6:e12956. doi: 10.1111/jsr.12956. [Epub ahead of print]

PMID:
31808986
3.

Cardiovascular Effect and Symptom Profile of Obstructive Sleep Apnea: Does Sex Matter?

Bouloukaki I, Mermigkis C, Markakis M, Pataka A, Alexaki I, Ermidou C, Moniaki V, Mauroudi E, Michelakis S, Schiza SE.

J Clin Sleep Med. 2019 Oct 25. pii: jc-19-00172. [Epub ahead of print]

PMID:
31648676
4.

Central sleep apnoea and periodic breathing in heart failure: prognostic significance and treatment options.

Randerath W, Deleanu O, Schiza S, Pepin JL.

Eur Respir Rev. 2019 Oct 11;28(153). pii: 190084. doi: 10.1183/16000617.0084-2019. Print 2019 Sep 30. Review. Erratum in: Eur Respir Rev. 2019 Nov 13;28(154):.

5.

Sleep in chronic respiratory disease: COPD and hypoventilation disorders.

McNicholas WT, Hansson D, Schiza S, Grote L.

Eur Respir Rev. 2019 Sep 25;28(153). pii: 190064. doi: 10.1183/16000617.0064-2019. Print 2019 Sep 30. Review.

6.

Unique sleep-stage transitions determined by obstructive sleep apnea severity, age and gender.

Wächter M, Kantelhardt JW, Bonsignore MR, Bouloukaki I, Escourrou P, Fietze I, Grote L, Korzybski D, Lombardi C, Marrone O, Paranicova I, Pataka A, Ryan S, Schiza SE, Sliwinski P, Steiropoulos P, Verbraecken J, Penzel T; ESADA Study Group.

J Sleep Res. 2019 Jul 25:e12895. doi: 10.1111/jsr.12895. [Epub ahead of print]

PMID:
31347213
7.

Cancer prevalence is increased in females with sleep apnoea: data from the ESADA study.

Pataka A, Bonsignore MR, Ryan S, Riha RL, Pepin JL, Schiza S, Basoglu OK, Sliwinski P, Ludka O, Steiropoulos P, Anttalainen U, McNicholas WT, Hedner J, Grote L; ESADA study group.

Eur Respir J. 2019 Jun 20;53(6). pii: 1900091. doi: 10.1183/13993003.00091-2019. Print 2019 Jun. No abstract available.

PMID:
31109987
8.

Use of the Clinical Global Impression scale in sleep apnea patients - Results from the ESADA database.

Dieltjens M, Verbraecken JA, Hedner J, Vanderveken OM, Steiropoulos P, Kvamme JA, Saaresranta T, Tkacova R, Marrone O, Dogas Z, Schiza S, Grote L; ESADA collaborators.

Sleep Med. 2019 Jul;59:56-65. doi: 10.1016/j.sleep.2018.10.028. Epub 2018 Nov 14.

PMID:
30555029
9.

The Association Between Adherence to Positive Airway Pressure Therapy and Long-Term Outcomes in Patients With Obesity Hypoventilation Syndrome: A Prospective Observational Study.

Bouloukaki I, Mermigkis C, Michelakis S, Moniaki V, Mauroudi E, Tzanakis N, Schiza SE.

J Clin Sleep Med. 2018 Sep 15;14(9):1539-1550. doi: 10.5664/jcsm.7332.

10.

Clinical presentation of patients with suspected obstructive sleep apnea and self-reported physician-diagnosed asthma in the ESADA cohort.

Bonsignore MR, Pepin JL, Anttalainen U, Schiza SE, Basoglu OK, Pataka A, Steiropoulos P, Dogas Z, Grote L, Hedner J, McNicholas WT, Marrone O; ESADA Study Group.

J Sleep Res. 2018 Dec;27(6):e12729. doi: 10.1111/jsr.12729. Epub 2018 Jul 11.

11.

Change in weight and central obesity by positive airway pressure treatment in obstructive sleep apnea patients: longitudinal data from the ESADA cohort.

Basoglu OK, Zou D, Tasbakan MS, Hedner J, Ryan S, Verbraecken J, Escourrou P, Antalainen U, Kvamme JA, Bonsignore MR, Schiza S, Grote L; ESADA Study Group.

J Sleep Res. 2018 Dec;27(6):e12705. doi: 10.1111/jsr.12705. Epub 2018 May 24.

12.

Evaluation of Inflammatory Markers in a Large Sample of Obstructive Sleep Apnea Patients without Comorbidities.

Bouloukaki I, Mermigkis C, Tzanakis N, Kallergis E, Moniaki V, Mauroudi E, Schiza SE.

Mediators Inflamm. 2017;2017:4573756. doi: 10.1155/2017/4573756. Epub 2017 Jul 31.

13.

Sleep as a New Target for Improving Outcomes in Idiopathic Pulmonary Fibrosis.

Mermigkis C, Bouloukaki I, Schiza SE.

Chest. 2017 Dec;152(6):1327-1338. doi: 10.1016/j.chest.2017.07.019. Epub 2017 Aug 1. Review.

PMID:
28774636
14.

The role of compliance with PAP use on blood pressure in patients with obstructive sleep apnea: is longer use a key-factor?

Bouloukaki I, Mermigkis C, Tzanakis N, Giannadaki K, Mauroudi E, Moniaki V, Kallergis EM, Schiza SE.

J Hum Hypertens. 2017 Feb;31(2):106-115. doi: 10.1038/jhh.2016.47. Epub 2016 Jul 28.

PMID:
27465978
15.

Multum non multa: airway distensibility by forced oscillations.

Mermigkis C, Schiza SE, Panagou P.

Monaldi Arch Chest Dis. 2016 Jun 22;81(1-2):746. doi: 10.4081/monaldi.2015.746.

16.

Expression of YKL-40 and MIP-1a proteins in exudates and transudates: biomarkers for differential diagnosis of pleural effusions? A pilot study.

Adamidi T, Soulitzis N, Neofytou E, Zannetos S, Georgiou A, Benidis K, Papadopoulos A, Siafakas NM, Schiza SE.

BMC Pulm Med. 2015 Dec 1;15:150. doi: 10.1186/s12890-015-0144-6.

17.

Tiotropium Respimat Soft Mist Inhaler versus HandiHaler to improve sleeping oxygen saturation and sleep quality in COPD.

Bouloukaki I, Tzanakis N, Mermigkis C, Giannadaki K, Moniaki V, Mauroudi E, Michelakis S, Schiza SE.

Sleep Breath. 2016 May;20(2):605-12. doi: 10.1007/s11325-015-1259-y. Epub 2015 Sep 25.

PMID:
26407963
18.

Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night.

Schiza S, Mermigkis C, Margaritopoulos GA, Daniil Z, Harari S, Poletti V, Renzoni EA, Torre O, Visca D, Bouloukaki I, Sourvinos G, Antoniou KM.

Eur Respir Rev. 2015 Jun;24(136):327-39. doi: 10.1183/16000617.00009114. Review.

19.

Obstructive sleep apnea syndrome and cardiovascular disease: The influence of C-reactive protein.

Bouloukaki I, Mermigkis C, Kallergis EM, Moniaki V, Mauroudi E, Schiza SE.

World J Exp Med. 2015 May 20;5(2):77-83. doi: 10.5493/wjem.v5.i2.77. eCollection 2015 May 20. Review.

20.

Insomnia and excessive daytime sleepiness in obstructive sleep apnea: only different clinical phenotypes?

Mermigkis C, Bouloukaki I, Schiza SE.

Sleep Breath. 2015 Dec;19(4):1395-7. doi: 10.1007/s11325-015-1170-6. Epub 2015 Apr 9. No abstract available.

PMID:
25855472
21.

Expiratory positive airway pressure (EPAP) nasal device therapy: a welcome addition to obstructive sleep apnea syndrome therapy.

Schiza SE, Mermigkis C, Bouloukaki I.

Sleep Breath. 2015 Sep;19(3):775-6. doi: 10.1007/s11325-014-1069-7. Epub 2015 Apr 7. No abstract available.

PMID:
25847320
22.

Leptin and leptin receptor gene polymorphisms and obstructive sleep apnea syndrome: is there an association?

Schiza SE, Mermigkis C, Bouloukaki I.

Sleep Breath. 2015 Sep;19(3):1079-80. doi: 10.1007/s11325-015-1139-5. Epub 2015 Feb 11. No abstract available.

PMID:
25666382
23.

Cost-effectiveness of CPAP treatment related to cardiovascular disease in patients with severe OSAS: the Greek experience.

Mermigkis C, Bouloukaki I, Schiza SE.

Sleep Breath. 2015 May;19(2):737-9. doi: 10.1007/s11325-014-1063-0. Epub 2014 Oct 11. No abstract available.

PMID:
25304123
24.

Implications of revised AASM rules on scoring apneic and hypopneic respiratory events in heart failure patients with nocturnal Cheyne-Stokes respiration.

Schiza SE, Mermigkis C, Bouloukaki I.

Sleep Breath. 2015 May;19(2):745-7. doi: 10.1007/s11325-014-1040-7. Epub 2014 Jul 25. No abstract available.

PMID:
25060193
25.

Obstructive sleep apnea should be treated in patients with idiopathic pulmonary fibrosis.

Mermigkis C, Bouloukaki I, Antoniou K, Papadogiannis G, Giannarakis I, Varouchakis G, Siafakas N, Schiza SE.

Sleep Breath. 2015 Mar;19(1):385-91. doi: 10.1007/s11325-014-1033-6. Epub 2014 Jul 16.

PMID:
25028171
26.

The influence of a clinical classification system on the management of patients with positional dependent obstructive sleep apnoea.

Schiza SE, Mermigkis C, Bouloukaki I.

Sleep Breath. 2015 May;19(2):741-3. doi: 10.1007/s11325-014-1037-2. Epub 2014 Jul 15. No abstract available.

PMID:
25023523
27.

Intensive versus standard follow-up to improve continuous positive airway pressure compliance.

Bouloukaki I, Giannadaki K, Mermigkis C, Tzanakis N, Mauroudi E, Moniaki V, Michelakis S, Siafakas NM, Schiza SE.

Eur Respir J. 2014 Nov;44(5):1262-74. doi: 10.1183/09031936.00021314. Epub 2014 Jul 3.

28.

Abnormal cytokine profile in patients with obstructive sleep apnea-hypopnea syndrome and erectile dysfunction.

Bouloukaki I, Papadimitriou V, Sofras F, Mermigkis C, Moniaki V, Siafakas NM, Schiza SE.

Mediators Inflamm. 2014;2014:568951. doi: 10.1155/2014/568951. Epub 2014 May 19.

29.

The effect of obstructive sleep apnea syndrome and snoring severity to intima-media thickening of carotid artery.

Schiza SE, Mermigkis C, Bouloukaki I.

Sleep Breath. 2015 Mar;19(1):25-7. doi: 10.1007/s11325-014-1016-7. Epub 2014 Jun 13. No abstract available.

PMID:
24925821
30.

The effect of weight loss on obstructive sleep apnea (OSA) severity and position dependence in the bariatric population.

Schiza SE, Mermigkis C, Bouloukaki I.

Sleep Breath. 2014 Dec;18(4):679-81. doi: 10.1007/s11325-014-0973-1. Epub 2014 Mar 18. No abstract available.

PMID:
24638264
31.

Hooking of the soft palate and a large cervical osteophyte: two troubles in the same airway.

Mermigkis C, Mermigkis D, Bouloukaki I, Alogdianakis V, Schiza SE.

Am J Med Sci. 2013 Dec;346(6):519-20. doi: 10.1097/MAJ.0b013e3182a2a0f5.

PMID:
24263081
32.

Molecular profiling of EGFR family in chronic obstructive pulmonary disease: correlation with airway obstruction.

Anagnostis A, Neofytou E, Soulitzis N, Kampas D, Drositis I, Dermitzaki D, Tzanakis N, Schiza S, Siafakas NM, Tzortzaki EG.

Eur J Clin Invest. 2013 Dec;43(12):1299-306. doi: 10.1111/eci.12178. Epub 2013 Oct 22.

PMID:
24147598
33.

Natural course of sleep disordered breathing after acute myocardial infarction.

Mermigkis C, Bouloukaki I, Schiza SE.

Eur Respir J. 2013 May;41(5):1238-9. doi: 10.1183/09031936.00195112. No abstract available.

34.

Obstructive sleep apnea in patients with interstitial lung diseases: past and future.

Mermigkis C, Bouloukaki I, Schiza SE.

Sleep Breath. 2013 Dec;17(4):1127-8. doi: 10.1007/s11325-013-0836-1. Epub 2013 Apr 12. No abstract available.

PMID:
23579857
35.

Epworth sleepiness scale scores and adverse pregnancy outcomes.

Schiza SE, Bouloukaki I, Mermigkis C.

Sleep Breath. 2013 Dec;17(4):1125-6. doi: 10.1007/s11325-013-0821-8. Epub 2013 Mar 13. No abstract available.

PMID:
23483324
36.

Medical treatment with thiamine, coenzyme Q, vitamins E and C, and carnitine improved obstructive sleep apnea in an adult case of Leigh disease.

Mermigkis C, Bouloukaki I, Mastorodemos V, Plaitakis A, Alogdianakis V, Siafakas N, Schiza S.

Sleep Breath. 2013 Dec;17(4):1129-35. doi: 10.1007/s11325-013-0816-5. Epub 2013 Feb 7.

PMID:
23389837
37.

CPAP therapy in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea: does it offer a better quality of life and sleep?

Mermigkis C, Bouloukaki I, Antoniou KM, Mermigkis D, Psathakis K, Giannarakis I, Varouchakis G, Siafakas N, Schiza SE.

Sleep Breath. 2013 Dec;17(4):1137-43. doi: 10.1007/s11325-013-0813-8. Epub 2013 Feb 6.

PMID:
23386371
38.

Translation and validation of Berlin questionnaire in primary health care in Greece.

Bouloukaki I, Komninos ID, Mermigkis C, Micheli K, Komninou M, Moniaki V, Mauroudi E, Siafakas NM, Schiza SE.

BMC Pulm Med. 2013 Jan 24;13:6. doi: 10.1186/1471-2466-13-6.

39.

Bone mineral density in patients with obstructive sleep apnea syndrome.

Schiza SE, Bouloukaki I, Mermigkis C.

Sleep Breath. 2013 Mar;17(1):17-8. doi: 10.1007/s11325-012-0699-x. Epub 2012 Apr 13. No abstract available.

PMID:
22528951
40.

Sleep disordered breathing in patients with acute coronary syndromes.

Schiza SE, Simantirakis E, Bouloukaki I, Mermigkis C, Kallergis EM, Chrysostomakis S, Arfanakis D, Tzanakis N, Vardas P, Siafakas NM.

J Clin Sleep Med. 2012 Feb 15;8(1):21-6. doi: 10.5664/jcsm.1652.

41.

Sleep apnea.

Alchanatis M, Macfarlane J, Schiza S.

Sleep Disord. 2012;2012:308978. doi: 10.1155/2012/308978. Epub 2012 Jun 13. No abstract available.

42.

Management of pregnancy and delivery of a patient with malfunctioning ventriculoperitoneal shunt.

Schiza S, Stamatakis E, Panagopoulou A, Valsamidis D.

J Obstet Gynaecol. 2012 Jan;32(1):6-9. doi: 10.3109/01443615.2011.622058.

PMID:
22185526
43.

Long-term omalizumab treatment in severe allergic asthma: the South-Eastern Mediterranean "real-life" experience.

Tzortzaki EG, Georgiou A, Kampas D, Lemessios M, Markatos M, Adamidi T, Samara K, Skoula G, Damianaki A, Schiza S, Tzanakis N, Siafakas NM.

Pulm Pharmacol Ther. 2012 Feb;25(1):77-82. doi: 10.1016/j.pupt.2011.11.004. Epub 2011 Dec 3.

PMID:
22155001
44.

Prediction formulas for nasal continuous positive airway pressure in patients with obstructive sleep apnea syndrome.

Schiza SE, Bouloukaki I.

Sleep Breath. 2012 Dec;16(4):941-3. doi: 10.1007/s11325-011-0613-y. Epub 2011 Nov 9. No abstract available.

PMID:
22083388
45.

Effect of Mediterranean diet versus prudent diet combined with physical activity on OSAS: a randomised trial.

Papandreou C, Schiza SE, Bouloukaki I, Hatzis CM, Kafatos AG, Siafakas NM, Tzanakis NE.

Eur Respir J. 2012 Jun;39(6):1398-404. doi: 10.1183/09031936.00103411. Epub 2011 Oct 27.

46.

Effect of Mediterranean diet on lipid peroxidation marker TBARS in obese patients with OSAHS under CPAP treatment: a randomised trial.

Papandreou C, Schiza SE, Tzatzarakis MN, Kavalakis M, Hatzis CM, Tsatsakis AM, Kafatos AG, Siafakas NM, Tzanakis NE.

Sleep Breath. 2012 Sep;16(3):873-9. doi: 10.1007/s11325-011-0589-7. Epub 2011 Sep 15.

PMID:
21918812
47.

CRP evolution pattern in CPAP-treated obstructive sleep apnea patients. Does gender play a role?

Mermigkis C, Bouloukaki I, Mermigkis D, Kallergis E, Mavroudi E, Varouchakis G, Tzortzaki E, Siafakas N, Schiza SE.

Sleep Breath. 2012 Sep;16(3):813-9. doi: 10.1007/s11325-011-0580-3. Epub 2011 Sep 1.

PMID:
21881894
48.

Gluteal adipose-tissue polyunsaturated fatty-acids profiles and depressive symptoms in obese adults with obstructive sleep apnea hypopnea syndrome: a cross-sectional study.

Papandreou C, Schiza SE, Tsibinos G, Mermigkis C, Hatzis CM, Kafatos AG, Siafakas NM, Fragkiadakis GA, Tzanakis NE.

Pharmacol Biochem Behav. 2011 Apr;98(2):316-9. doi: 10.1016/j.pbb.2011.01.016. Epub 2011 Jan 31.

PMID:
21281660
49.

CPAP treatment in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea--therapeutic difficulties and dilemmas.

Mermigkis C, Mermigkis D, Varouchakis G, Schiza S.

Sleep Breath. 2012 Mar;16(1):1-3. doi: 10.1007/s11325-010-0476-7. Epub 2011 Jan 9. No abstract available.

PMID:
21221822
50.

Prediction of obstructive sleep apnea syndrome in a large Greek population.

Bouloukaki I, Kapsimalis F, Mermigkis C, Kryger M, Tzanakis N, Panagou P, Moniaki V, Vlachaki EM, Varouchakis G, Siafakas NM, Schiza SE.

Sleep Breath. 2011 Dec;15(4):657-64. doi: 10.1007/s11325-010-0416-6. Epub 2010 Sep 25.

PMID:
20872180

Supplemental Content

Loading ...
Support Center